Clark Estates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Clark Estates's BMY Position: Q3 2026 in Review
Clark Estates sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 43,000 shares — an estimated $2.48M sold.
Clark Estates first reported a position in BMY in Q1 2020 and held it in 25 quarters. The position peaked at $8.14M in Q3 2020. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Clark Estates reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
- Clark Estates sold 43,000 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.48M.
- Clark Estates first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 25 quarters.
- Clark Estates's Bristol-Myers Squibb position peaked at $8.14M in Q3 2020.
- 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Clark Estates's 13F filing for Q3 2026, filed 10 Nov 2026.